NEW
YORK, March 11, 2025 /PRNewswire/ -- Rowley Law
PLLC is investigating potential securities law violations by
2seventy bio, Inc. (NASDAQ: TSVT) and its board of directors
concerning the proposed acquisition of the company by Bristol Myers
Squibb (NYSE: BMY). Stockholders will receive $5.00 for each share of 2seventy bio stock that
they hold. The transaction is valued at approximately $286 million and is expected to close in the
second quarter of 2025.
If you are a stockholder of 2seventy bio, Inc. and are
interested in obtaining additional information regarding this
investigation, please visit us
at: http://www.rowleylawpllc.com/investigation/tsvt/.
You may also contact Shane Rowley,
Esq. at Rowley Law PLLC, 50 Main Street Suite 1000,
White Plains, NY 10606, by email
at info@rowleylawpllc.com, or by telephone at 914-400-1920
or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View original
content:https://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-2seventy-bio-inc-302398894.html
SOURCE Rowley Law PLLC
